Cooper Return on Investment 2010-2022 | COO

Current and historical return on investment (ROI) values for Cooper (COO) over the last 10 years.
Cooper ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-07-31 $0.53B $9.43B 5.87%
2022-04-30 $0.49B $9.36B 5.66%
2022-01-31 $0.50B $9.27B 6.10%
2021-10-31 $0.51B $8.34B 6.49%
2021-07-31 $0.48B $7.97B 6.80%
2021-04-30 $0.45B $7.49B 7.11%
2021-01-31 $0.33B $7.40B 5.89%
2020-10-31 $0.31B $5.21B 6.17%
2020-07-31 $0.36B $5.09B 7.21%
2020-04-30 $0.43B $4.97B 8.64%
2020-01-31 $0.55B $4.97B 10.99%
2019-10-31 $0.55B $4.89B 10.91%
2019-07-31 $0.52B $5.04B 10.23%
2019-04-30 $0.50B $5.02B 9.51%
2019-01-31 $0.43B $5.11B 7.90%
2018-10-31 $0.40B $5.29B 7.37%
2018-07-31 $0.39B $5.48B 7.44%
2018-04-30 $0.39B $5.63B 7.84%
2018-01-31 $0.43B $5.53B 9.32%
2017-10-31 $0.43B $4.33B 10.18%
2017-07-31 $0.40B $4.27B 9.65%
2017-04-30 $0.39B $4.29B 9.47%
2017-01-31 $0.36B $4.02B 8.88%
2016-10-31 $0.32B $3.80B 8.08%
2016-07-31 $0.29B $4.15B 7.29%
2016-04-30 $0.24B $4.16B 6.11%
2016-01-31 $0.22B $3.94B 5.79%
2015-10-31 $0.24B $3.78B 6.26%
2015-07-31 $0.23B $3.76B 6.14%
2015-04-30 $0.28B $3.72B 7.78%
2015-01-31 $0.30B $3.82B 8.81%
2014-10-31 $0.31B $3.87B 9.85%
2014-07-31 $0.33B $2.98B 11.66%
2014-04-30 $0.33B $2.86B 11.89%
2014-01-31 $0.32B $2.76B 11.86%
2013-10-31 $0.31B $2.73B 11.51%
2013-07-31 $0.32B $2.65B 12.34%
2013-04-30 $0.31B $2.63B 11.81%
2013-01-31 $0.29B $2.63B 11.54%
2012-10-31 $0.28B $2.56B 11.63%
2012-07-31 $0.27B $2.55B 11.49%
2012-04-30 $0.25B $2.31B 10.72%
2012-01-31 $0.24B $2.31B 10.48%
2011-10-31 $0.23B $2.27B 9.91%
2011-07-31 $0.22B $2.29B 9.74%
2011-04-30 $0.22B $2.33B 9.78%
2011-01-31 $0.20B $2.31B 8.95%
2010-10-31 $0.19B $2.26B 8.45%
2010-07-31 $0.17B $2.22B 7.47%
2010-04-30 $0.15B $2.24B 6.65%
2010-01-31 $0.15B $2.28B 6.71%
2009-10-31 $0.15B $2.31B 6.55%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.294B $2.923B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.488B 18.73
McKesson (MCK) United States $49.156B 14.27
AmerisourceBergen (ABC) United States $28.202B 12.59
Laboratory Of America Holdings (LH) United States $19.282B 8.43
West Pharmaceutical Services (WST) United States $18.606B 28.33
Cardinal Health (CAH) United States $17.762B 13.40
CONMED (CNMD) United States $2.498B 24.62
Invacare (IVC) United States $0.028B 0.00